QSS
GYRE icon

Quantitative Systematic Strategies’s Gyre Therapeutics GYRE Stock Holding History

Quantitative Systematic Strategies’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,170
Closed -$70K – 166
2021
Q2 		$70K Sell
2,170
-1,830
-46% -$62.8K 0.02% 441
2021
Q1 		$151K Buy
+4,000
New +$183K 0.02% 578
2019
Q1 		– Sell
-1,506
Closed -$89K – 502
2018
Q4 		$89K Buy
+1,506
New +$111K 0.02% 617
2018
Q3 		– Sell
-1,372
Closed -$120K – 691
2018
Q2 		$120K Buy
+1,372
New +$241K 0.02% 588

Other funds holding GYRE

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Quantitative Systematic Strategies's GYRE Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of Gyre Therapeutics (GYRE) in Q3 2021, closing a stake of 2,170 shares — an estimated $70K sold.

Quantitative Systematic Strategies first reported a position in GYRE in Q2 2018 and held it in 4 quarters. The position peaked at $151K in Q1 2021. 65 funds tracked by Wall St. Rank hold GYRE as of Q3 2021.

  • Quantitative Systematic Strategies reported no remaining Gyre Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 2,170 Gyre Therapeutics shares in Q3 2021, an estimated $70K.
  • Quantitative Systematic Strategies first reported a position in Gyre Therapeutics in Q2 2018 and held it in 4 quarters.
  • Quantitative Systematic Strategies's Gyre Therapeutics position peaked at $151K in Q1 2021.
  • 65 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.